InvestorsHub Logo
Followers 8
Posts 1906
Boards Moderated 0
Alias Born 09/10/2012

Re: None

Tuesday, 05/09/2023 7:07:41 AM

Tuesday, May 09, 2023 7:07:41 AM

Post# of 3283
- Q1 2023 net sales of $15.6 million, an increase of 54% compared to Q4 2022 --

-- Company to be acquired by Assertio Holdings, Inc., delivering value to stakeholders in an all stock and contingent value rights (CVR) transaction --

-- Transaction expected to close in Q3 2023 --

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a commercial stage biopharmaceutical company focused on novel and targeted oncology therapies, announced today financial results for the three-month period ended March 31, 2023, and provided a corporate update.

The Company had a total cash, cash equivalents, and marketable securities balance of approximately $56.1 million as of March 31, 2023.